ABBVIE, INC. for ABBVIE INC.

Health Issues HCR

H.R. 6, H.R. 34 & Public Law 114-255, 21st Century Cures Act; S. 2700, FDA and NIH Workforce Authorities Modernization Act; H.R. 3381, Childhood Cancer STAR Act; Discussions to clarify or reform the 340B program; Biologics Price Competition and Innovation Act; Public Law 111-148, The Patient Protection and Affordable Care Act; Public Law 111-152, The Health Care and Education Reconciliation Act; H.R. 2228 & S.122, Safe and Affordable Drugs from Canada Act of 2015; Proposals to address prescription drug abuse; Implementation/Reauthorization of The Prescription Drug User Fee Act (PDUFA); Implementation/Reauthorization of The Biosimilars User Fee Act (BsUFA); H.R. 639 & S. 481, Improving Regulatory Transparency for New Medical Therapies; H.R. 2570 & S. 1396, Value-Based Insurance Design Seniors Copayment Reduction Act of 2015; H.R. 3012 & S. 2912, Trickett Wendler Right to Try Act of 2016; H.R. 6043 & S. 3335, Fair Accountability and Innovative Research Drug Pricing Act of 2016; S.3239, RACE for Children Act; Expanded Access (legislation not introduced) H.R. 4207, Medicare Fair Drug Pricing Act of 2015; Clinton's 1993 Health Security Act; S. 2023, Prescription Drug Affordability Act of 2015; H.R. 6501, Prescription Drug and Medical Device Price Review Board Act of 2016; S.3455, Pharmaceutical Supply and Value Enhancement Act; Repeal and Replace Proposals for Public Law 111-148, The Patient Protection and Affordable Care Act (no legislation introduced);

Contacted: Health Resources & Services Administration (HRSA); Patent & Trademark Office (PTO); State, Dept of (DOS); Medicare Payment Advisory Commission (MedPAC); U.S. Trade Representative (USTR); SENATE; Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3381 (114th), S. 3455 (114th), S. 3335 (114th), H.R. 4207 (114th), H.R. 6043 (114th), S. 2700 (114th), S. 122 (114th), S. 3239 (114th), S. 2023 (114th), H.R. 6501 (114th), H.R. 2570 (114th), S. 1396 (114th), H.R. 6 (114th), H.R. 34 (114th), H.R. 639 (114th), H.R. 3012 (114th), H.R. 2228 (114th), S. 2912 (114th), S. 481 (114th)

Medicare/Medicaid MMM

Policies to enhance patient access to medicines in Medicaid; Policies to enhance patient access to medicines in Medicare; H.R. 3061 & S. 31, Medicare Prescription Drug Price Negotiation Act of 2015; H.R. 2005 & S. 1083, Medicare Drug Savings Act; H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models; Medicare payment proposals (MedPAC); Medicare Access and CHIP Reauthorization Act (MACRA);

Contacted: Patent & Trademark Office (PTO); U.S. Trade Representative (USTR); SENATE; Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Medicare Payment Advisory Commission (MedPAC); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC)

Bills named: H.R. 5122 (114th), H.R. 2005 (114th), S. 31 (114th), S. 1083 (114th), H.R. 3061 (114th)

Copyright/Patent/Trademark CPT

S. 632, STRONG Patents Act of 2015; S. 2733, Venue Equity and Non-Uniformity Elimination Act of 2016; H.R. 5573 & S. 3094, Price Relief, Innovation, and Competition for Essential Drugs (PRICED) Act; S. 3056, CREATES Act of 2016; Proposals/Initiatives related to international intellectual property protection;

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); Health Resources & Services Administration (HRSA); Patent & Trademark Office (PTO); Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); SENATE; Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES

Bills named: S. 3056 (114th), S. 2733 (114th), H.R. 5573 (114th), S. 3094 (114th), S. 632 (114th)

Budget/Appropriations BUD

H.R. 2028 & Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, 2017; Other Labor, Health and Human Services Appropriations (no bills introduced); S. 1413, FDA User Fee Protection Act;

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Commerce, Dept of (DOC); SENATE; U.S. Trade Representative (USTR)

Bills named: H.R. 2028 (114th), S. 1413 (114th)

Trade (domestic/foreign) TRD

Trans-Atlantic Trade and Investment Partnership; Trans-Pacific Partnership Agreement; Japan Pricing and Regulatory Issues; Egypt Exchange Rate and Pricing Issues; Colombia Potential Compulsory Licensing Issue;

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS); Health Resources & Services Administration (HRSA); Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Medicare Payment Advisory Commission (MedPAC); Patent & Trademark Office (PTO)

Taxation/Internal Revenue Code TAX

Senate and House Committee Tax Reform Proposals; H.R. 5278, PROMESA; Puerto Rican Economy and Debt Relief Proposals (no bills introduced); Proposals to reform domestic and international tax structures (no bills introduced);

Contacted: U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); Health Resources & Services Administration (HRSA); SENATE; Medicare Payment Advisory Commission (MedPAC); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); State, Dept of (DOS)

Bills named: H.R. 5278 (114th)